Your browser doesn't support javascript.
loading
Combination therapy of Tocilizumab and steroid for management of COVID-19 associated cytokine release syndrome: A single center experience from Pune, Western India.
Dravid, Ameet; Kashiva, Reema; Khan, Zafer; Memon, Danish; Kodre, Aparna; Potdar, Prashant; Mane, Milind; Borse, Rakesh; Pawar, Vishal; Patil, Dattatraya; Banerjee, Debashis; Bhoite, Kailas; Pharande, Reshma; Kalyani, Suraj; Raut, Prathamesh; Bapte, Madhura; Mehta, Anshul; Reddy, M Sateesh; Bhayani, Krushnadas; Laxmi, S S; Vishnu, P D; Srivastava, Shipra; Khandelwal, Shubham; More, Sailee; Shinde, Rohit; Pawar, Mohit; Harshe, Amol; Kadam, Sagar; Mahajan, Uma; Joshi, Gaurav; Mane, Dilip.
Afiliación
  • Dravid A; Department of Infectious Diseases and HIV/AIDS, Noble hospital and Research Centre, Pune, Maharashtra, India.
  • Kashiva R; Department of Medicine, Noble hospital and Research Centre, Pune, Maharashtra, India.
  • Khan Z; Department of Critical Care Medicine, Noble hospital and Research Centre, Pune, Maharashtra, India.
  • Memon D; Department of Medicine, Noble hospital and Research Centre, Pune, Maharashtra, India.
  • Kodre A; Department of Medicine, Noble hospital and Research Centre, Pune, Maharashtra, India.
  • Potdar P; Department of Medicine, Noble hospital and Research Centre, Pune, Maharashtra, India.
  • Mane M; Department of Critical Care Medicine, Noble hospital and Research Centre, Pune, Maharashtra, India.
  • Borse R; Department of Critical Care Medicine, Noble hospital and Research Centre, Pune, Maharashtra, India.
  • Pawar V; Department of Critical Care Medicine, Noble hospital and Research Centre, Pune, Maharashtra, India.
  • Patil D; Department of Critical Care Medicine, Noble hospital and Research Centre, Pune, Maharashtra, India.
  • Banerjee D; Department of Critical Care Medicine, Noble hospital and Research Centre, Pune, Maharashtra, India.
  • Bhoite K; Department of Critical Care Medicine, Noble hospital and Research Centre, Pune, Maharashtra, India.
  • Pharande R; Department of Critical Care Medicine, Noble hospital and Research Centre, Pune, Maharashtra, India.
  • Kalyani S; Department of Critical Care Medicine, Noble hospital and Research Centre, Pune, Maharashtra, India.
  • Raut P; Department of Critical Care Medicine, Noble hospital and Research Centre, Pune, Maharashtra, India.
  • Bapte M; Department of Critical Care Medicine, Noble hospital and Research Centre, Pune, Maharashtra, India.
  • Mehta A; Department of Medicine, Noble hospital and Research Centre, Pune, Maharashtra, India.
  • Reddy MS; Department of Medicine, Noble hospital and Research Centre, Pune, Maharashtra, India.
  • Bhayani K; Department of Medicine, Noble hospital and Research Centre, Pune, Maharashtra, India.
  • Laxmi SS; Department of Medicine, Noble hospital and Research Centre, Pune, Maharashtra, India.
  • Vishnu PD; Department of Medicine, Noble hospital and Research Centre, Pune, Maharashtra, India.
  • Srivastava S; Department of Medicine, Noble hospital and Research Centre, Pune, Maharashtra, India.
  • Khandelwal S; Department of Medicine, Noble hospital and Research Centre, Pune, Maharashtra, India.
  • More S; Department of Medicine, Noble hospital and Research Centre, Pune, Maharashtra, India.
  • Shinde R; Department of Medicine, Noble hospital and Research Centre, Pune, Maharashtra, India.
  • Pawar M; Department of Medicine, Noble hospital and Research Centre, Pune, Maharashtra, India.
  • Harshe A; Department of Pathology, Noble hospital and Research Centre, Pune, Maharashtra, India.
  • Kadam S; Department of Radiology, Noble hospital and Research Centre, Pune, Maharashtra, India.
  • Mahajan U; VMK Diagnostics Private Limited, Pune, Maharashtra, India.
  • Joshi G; Independent statistical consultant, Chicago.
  • Mane D; Department of Medicine, Noble hospital and Research Centre, Pune, Maharashtra, India.
Medicine (Baltimore) ; 100(29): e26705, 2021 Jul 23.
Article en En | MEDLINE | ID: mdl-34398044

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Dexametasona / Metilprednisolona / Anticuerpos Monoclonales Humanizados / Síndrome de Liberación de Citoquinas / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Medicine (Baltimore) Año: 2021 Tipo del documento: Article País de afiliación: India

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Dexametasona / Metilprednisolona / Anticuerpos Monoclonales Humanizados / Síndrome de Liberación de Citoquinas / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Medicine (Baltimore) Año: 2021 Tipo del documento: Article País de afiliación: India